RHON-KLINIKUM AG Unsponsored ADR
RKAGY · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $429 | $419 | $415 | $425 |
| % Growth | 2.4% | 1% | -2.3% | – |
| Cost of Goods Sold | $424 | $421 | $140 | $249 |
| Gross Profit | $5 | -$2 | $274 | $176 |
| % Margin | 1.1% | -0.4% | 66.2% | 41.3% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$5 | -$11 | $266 | $157 |
| Operating Expenses | -$5 | -$11 | $266 | $157 |
| Operating Income | $10 | $9 | $8 | $19 |
| % Margin | 2.4% | 2.2% | 1.9% | 4.4% |
| Other Income/Exp. Net | $1 | $1 | $1 | $2 |
| Pre-Tax Income | $11 | $10 | $9 | $20 |
| Tax Expense | $1 | $3 | $2 | $5 |
| Net Income | $10 | $7 | $7 | $14 |
| % Margin | 2.3% | 1.7% | 1.7% | 3.3% |
| EPS | 0.07 | 0.05 | 0.055 | 0.11 |
| % Growth | 40% | -9.1% | -50% | – |
| EPS Diluted | 0.07 | 0.05 | 0.055 | 0.11 |
| Weighted Avg Shares Out | 140 | 140 | 130 | 129 |
| Weighted Avg Shares Out Dil | 140 | 140 | 130 | 129 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2 | $2 | $2 | $2 |
| Interest Expense | $1 | $1 | $1 | $1 |
| Depreciation & Amortization | $15 | $15 | $15 | $17 |
| EBITDA | $27 | $26 | $25 | $38 |
| % Margin | 6.2% | 6.2% | 5.9% | 9% |